Does the use of higher versus lower oxygen concentration improve neurodevelopmental outcomes at 18-24 months in very low birthweight infants?
Georg M Schmölzer, Elizabeth V Asztalos, Marc Beltempo...
https://pubmed.ncbi.nlm.nih.gov/38576007/Actively Recruiting
Led by University of Alberta · Updated on 2026-05-26
1200
Participants Needed
21
Research Sites
117 weeks
Total Duration
Preterm birth, defined as birth before 37 weeks of gestation, occurs in about 8 percent of pregnancies in Canada and is linked to many health challenges, especially when it happens before 29 weeks. At this early stage, infants often face breathing difficulties and may require resuscitation. This trial compares resuscitation using either low 30% or high 60% oxygen levels to determine which approach results in better survival and neurodevelopmental outcomes at around 24 months of age. The study uses a cluster randomized crossover design where hospitals alternate between starting resuscitation with 30% or 60% oxygen for groups of 30 infants. Resuscitation includes standard care steps like lung expansion and ventilation support as needed. Oxygen is initially given at the assigned concentration for the first 5 minutes, then adjusted based on the infants oxygen saturation levels and heart rate over the next 5 minutes to maintain target saturation ranges. This approach aims to balance risks of too much or too little oxygen. Participants are infants born between 23 and 28 weeks gestation who receive full resuscitation at participating centers. During the study, infants have oxygen saturation monitored continuously, and adjustments to oxygen concentration are made carefully. Researchers will evaluate survival and major neurodevelopmental outcomes at 24 months corrected age, along with several safety and health measures during the neonatal intensive care stay. The trial is expected to provide important evidence to guide oxygen use during resuscitation of extremely preterm infants.
CONDITIONS
30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants
G
Georg Schmolzer, MD, PhD
B
Barb Kamstra, RN
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Alberta
Lead Sponsor
University of Toronto
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 10 minutes
Participants receive either 30% or 60% oxygen at birth for the first 5 minutes during resuscitation. Oxygen levels may be adjusted between 5 and 10 minutes after birth to maintain target oxygen saturation levels.
1 visit (in-person, at birth and immediate monitoring)
Duration - Approximately 24 months
Participants are monitored for neurodevelopmental outcomes and survival up to 24 months corrected age, including assessments of mortality and major neurodevelopmental conditions.
Visits as needed for assessments up to 24 months corrected age
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Georg M Schmölzer, Elizabeth V Asztalos, Marc Beltempo...
https://pubmed.ncbi.nlm.nih.gov/38576007/University of Alberta
Lead Sponsor
University of Toronto
Collaborating Sponsor